Performance of Ultrasound in the Early Diagnosis of Vocal Cords Paralysis (PECV)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03727217|
Recruitment Status : Recruiting
First Posted : November 1, 2018
Last Update Posted : November 7, 2018
Thyroid and parathyroid surgery concerns around 50 000 patients a year in France. One of its main complications is paralysis of vocal cords, and the consequences can be serious.
In this study, the main gold is to evaluate diagnostic performances of ultrasound for an early diagnosis (as soon as awakening of the patient) of vocal cords paralysis in the post-operative period in order to prevent at best complications.
|Condition or disease||Intervention/treatment||Phase|
|Thyroidectomy Paralysis of Vocal Cords||Diagnostic Test: Pre and postoperative ultrasound||Not Applicable|
Thyroid and parathyroid surgery concerns around 50 000 patients a year in France. One of its main complications is paralysis of vocal cords. Indeed, the anatomy of the thyroid and its close location with the recurrent laryngeal nerve (responsible for the vocal cord movement) involves a possible lesion or inflammation of the nerve during the surgical procedure. This complication is common, affecting around 10% of thyroid or parathyroid patients following surgery. This complication can be reversible, with a speech therapy or a specific endoscopic treatment by an otolaryngologist.
Currently, a postoperative screening is performed by nasofibroscopy in the recovery room to directly visualize vocal cord mobility. This examination may be painful or badly tolerated by some patients.
Recent studies have highlighted the performance of ultrasound in this diagnosis. The protocol for these studies included an ultrasound distant of the intervention, while it is known that vocal cord paralysis may have earlier consequences.
In this study, the investigators would like to evaluate diagnostic performances of vocal cords ultrasound for an early diagnosis (as soon as awakening of the patient) of vocal cords paralysis in the post-operative period in order to prevent at best complications.
The main limitation of vocal cord ultrasound is mainly related to surgery. Surgery creates anatomical rearrangements, so the secondary objective of this study will be to test whether the preoperative visualization is predictive of a good postoperative visualization.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Performance of Ultrasound in the Early Diagnosis of Vocal Cords Paralysis After Thyroidectomy or Parathyroidectomy (PECV)|
|Actual Study Start Date :||July 12, 2018|
|Estimated Primary Completion Date :||July 2020|
|Estimated Study Completion Date :||July 2020|
Experimental: Pre and postoperative ultrasound
An ultrasound is performed in preoperative and in postoperative.
Diagnostic Test: Pre and postoperative ultrasound
An ultrasound is performed in preoperative and in postoperative
- Diagnostic performance comparison between ultrasound and nasofibroscopy [ Time Frame: one hour after surgery ]Diagnostic performances (sensitivity, specificity, positive and negative predictive value) of the immediate postoperative ultrasound (within one hour after the end of surgery), the gold standard being nasofibroscopy.
- Frequency distribution of quality of ultrasound visualization (good or bad) measured by contingency tables [ Time Frame: before surgery (same day), one hour after surgery ]Link between the good visualization of the vocal cords by preoperative ultrasound and postoperative ultrasound.
- Time for performing ultrasound [ Time Frame: one hour after surgery ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03727217
|Contact: Amélie Lansiaux, Md, PhD||+33 3 20 22 52 69 ext +firstname.lastname@example.org|
|Contact: Anne-Sophie Blain, CRA||+33 3 22 57 32 ext +email@example.com|
|Lille Catholic Hospitals||Recruiting|
|Lomme, Nord, France, 59462|
|Contact: Amélie Lansiaux, Md, PhD +33 3 20 22 52 69 ext +33 firstname.lastname@example.org|
|Contact: Anne-Sophie Blain, CRA +33 3 20 22 57 32 ext +33 email@example.com|
|Principal Investigator: Claire Texier, Dr|
|Principal Investigator:||Claire Texier, Dr||Lille Catholic University|